Medexus Pharmaceuticals Inc. endeavors to share all the information that our investors require in order to make informed investment decisions. For questions regarding our business operations, partnerships, our product pipeline/portfolio, or for general inquiries, please reach out us using the form provided.
Medexus Pharmaceuticals, Inc.
10 King Street East, Suite 600
Toronto, Ontario,
Canada
M5C 1C3
T: 877-422-5242
business.development@medexus.com
Victoria Rutherford
Adelaide Capital
T: 480-625-5772
E-mail: victoria@adcap.ca
Direct Financial Strategies and Communication Inc.
Frank Candido
frank@directfinancial-ir.com
T: 514-969-5530
USA: For adverse events, medical inquiries, and product-related concerns, please call 1-855-336-3322.
Canada: For adverse events, medical inquiries, and product-related concerns, please call 1-877-633-3987 or by written at MedexusPV@innomar-strategies.com.